Foley Attorneys Publish on Telemedicine Considerations for Decentralized Clinical Trials
January 14, 2025
Applied Clinical Trials
Foley & Lardner LLP attorneys Jessica Warwick, Kyle Faget, and Monica Chmielewski authored the Applied Clinical Trials article, “Telemedicine Considerations When Conducting Decentralized Clinical Trials.”
“Decentralized clinical trials (DCTs) involve some or all trial-related activities conducted at locations other than traditional clinical trial sites, such as via telemedicine or in a clinical trial participant’s home,” the authors write. “The use of telemedicine in DCTs implicates various state legal and regulatory considerations as the performance of research, or the performance of certain procedures within a clinical trial, may and often fall within and are deemed to be the ‘practice of medicine.'”
People
Related News
February 20, 2026
In the News
Gregory Husisian Weighs in on Impact, Next Steps in Wake of SCOTUS Tariff Ruling
Foley & Lardner LLP partner Gregory Husisian generated widespread media coverage discussing the SCOTUS ruling that President Donald Trump improperly used the International Emergency Powers Act (IEEPA) to impose tariffs.
February 19, 2026
In the News
Foley's California Growth, Four Partner Additions Garner Widespread Media Coverage
Foley & Lardner LLP's recent addition of partners Peter Stockburger, Matt Browne, Darby Chan, and Sanjeet Dutta — exemplifying the firm's continued strategic growth in California — garnered widespread media coverage.
February 19, 2026
In the News
Foley Attorneys Highlighted for Perspective on New PBM Transparency Rules
Foley & Lardner LLP partner Nick Welle, senior counsel Hannah Demsien, and associate Iris Grossman were highlighted in the BenefitPro article, “New federal law clashes with DOL proposal over who pays for PBM audits,” for their perspective on the conflict between the pharmacy benefit manager (PBM) audit laws and draft Department of Labor (DOL) regulations.